• 410.696.5080
  • info@myscrs.org
  • Join SCRS
  • Member Login
scrs-logoscrs-logoscrs-logoscrs-logo
  • About SCRS
    • Our Mission
    • Meet the Team
    • Leadership Council
    • Committees
  • Partnerships
    • Global Impact Partners
    • Corporate Partnership Categories
    • Event Sponsorships
    • Resource Network
  • Learning Campus
    • Webinar Access
    • Site Management Modules
    • RECIST Training Modules
    • CLEAR Contract Language
    • Inclusion in Clinical Trials
    • DCT & Connected Devices Guides
  • Membership
    • Join SCRS
    • Member Portal Login
    • Mentorship Program
    • Best Site Practices
    • Site Directory
    • Online Member Community
      • SCRS Community Rules
    • Good Clinical Practice (GCP) Training
    • Career Center
  • Advocacy
    • Site Advocacy Groups
    • Inclusion in Clinical Trials
    • Digital Innovation Initiative
    • Oncology Program
    • Payment Initiative
    • Collaborate Forward
    • Workforce
    • Get Involved
  • Summits & Events
    • Summits
    • Ambassador Program
      • Africa
      • Asia
      • Latin America
    • Awards
  • Resources
    • White Papers
    • InSite Journal
    • InFocus Newsletter
    • Press Releases
    • Podcast
    • Site Invoiceables Toolkit
    • Career Center
  • Join SCRS
✕
  • Home
  • Blog
  • News
  • Quintiles Wins Society for Clinical Research Sites’ 2014 Eagle Award

Quintiles Wins Society for Clinical Research Sites’ 2014 Eagle Award

October 15, 2014

Quintiles Wins Society for Clinical Research Sites’ 2014 Eagle Award
Recognized for leadership and professionalism in site support two years in a row

Ellicott City, M.D., October 15, 2014 – The Society for Clinical Research Sites (SCRS) announced at the 2014 Site Solutions Summit that Quintiles was awarded the 2014 Clinical Research Organization (CRO) Eagle Award. The award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication, was presented on October 11, 2014, at the Eagle Award Gala.

“We are delighted to present the Eagle Award to Quintiles,” said SCRS President Christine Pierre. The award reflects the opinions of almost 2,000 investigative sites across the globe. Quintiles’ integrity in consistently demonstrating their keen interest in partnering with sites landed them with this prestigious recognition.”

“It is such an honor to be recognized again and receive this award for the second year in a row,” said Lindy Jones, senior vice president, Integrated Site Services, Quintiles. “Our ambition of transforming clinical development and accelerating pipelines to achieve better patient outcomes is only possible through the dedication and hard work of our investigators and sites. I would like to thank the investigators who voted for us. We will continue to look at how we can better partner together.”

Prior to the Site Solutions Summit, SCRS members, which are investigative sites, were invited to nominate the sponsor and CRO they believe best demonstrates partnership commitment. The other criteria include: availability of qualified staff to support the sites, demonstration of collaboration, protocol design and execution, financial consideration, and partnering with sites for future work. The finalists were those sponsors and CROs that ranked in the 75th percentile or greater of nominations received. Once the finalists were identified, voting was open to all sites globally.

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 1,500 research sites, including 26,000 research professionals; 15,000 investigators and 9,000 research staff, in 39 countries. SCRS’ mission is to unify the voice of the global clinical research site community for site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

About Quintiles

Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 29,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Contact:
Amanda Ascoli
Communications Associate
Society for Clinical Research Sites
410.696.5080 x120
amanda.ascoli@myscrs.org

Mari Mansfield
Media Relations

+1.919.998.2639 (office) +1.919.259.3298 (mobile)
mari.mansfield@quintiles.com

Karl Deonanan
Investor Relations

+1.919.998.2789
InvestorRelations@quintiles.com

Share

Related posts

February 25, 2025

Novotech Joins SCRS Global Impact Partner Program to Strengthen Site-CRO Collaboration in Clinical Research


Read more
February 20, 2025

SCRS and Fortrea Partner to Advance Collaboration in Clinical Research


Read more
February 19, 2025

Verdiva Bio Joins Society for Clinical Research Sites (SCRS) as a Global Impact Partner


Read more

phone +1 410.696.5080
info@myscrs.org

SOCIAL

 

Join Today
Join a Summit
© 2024, SCRS, all rights reserved. | Designed by Baltimore Web Design

Policies | Terms of Use

    • Join SCRS
    • Member Login